Fact checked by Jennifer Klump Key Takeaways The FDA has removed the black box warning on hormone therapy, which had ...

Lea Didion didn’t realize the night sweats she began experiencing in her 40s might be a sign of perimenopause. Her doctor clued her in and suggested she consider hormone replacement therapy, a ...

Noninferiority seen in three-year metastasis-free survival for men with locally advanced prostate cancer. (HealthDay News) — For men with locally advanced prostate cancer, transdermal estradiol (tE2) ...

Abstract: This paper presents a design of a high gain cavity-backed circular patch antenna. By using substrate integrated waveguide (SIW) based cavity and feeding mechanism. This proposed antenna aims ...

The researchers found that the observed 3-year metastasis-free survival was 87.1 and 85.9% with transdermal estradiol patches and luteinizing hormone-releasing hormone agonists, respectively.

FRIDAY, April 10, 2026 (HealthDay News) -- For men with locally advanced prostate cancer, transdermal estradiol (tE2) patches are noninferior to luteinizing hormone-releasing hormone (LHRH) agonists ...

Demand for estrogen patches surged 26% after the FDA removed a black box warning on hormone therapy in 2025 Shutterstock Demand for estrogen patches surged 26% after the FDA removed a black box ...

Add Yahoo as a preferred source to see more of our stories on Google. Demand for estrogen patches surged 26% after the FDA removed a black box warning on hormone therapy in 2025 Pharmacies are ...

Skyrocketing demands for estrogen patches have led to a shortage of the medication. A representative for CVS Health, the largest pharmacy chain in the U.S., confirmed the shortage, telling PEOPLE, ...

AUGUSTA, Ga. — One boy was white, and soon after World War II his father became the proprietor of the Augusta Municipal Golf Course. There was inherent middle-class status to the job, as the son came ...